Program Committee

Say “hello” to this year’s Program Committee!  ISPOR is excited to work with an amazing group of talented and passionate members dedicated to curating a robust slate of sessions and building an impactful program. It’s through their collaboration with ISPOR that we can deliver a meaningful experience to attendees.

Co-Chairs

Yannis Natsis
Yannis Natsis, MA
Director, European Social Insurance Platform (ESIP), Belgium
Patrice Verpillat
Patrice Verpillat, MD, MPH, PhD
Head of the Real-World Evidence (TDA-RWE), Data Analytics and Methods Task Force (TDA), European Medicines Agency, the Netherlands
Anne Willemesen
Anne Willemsen, MSc
Advisor, Co-Chair JCA Subgroup under the HTA Coordination Group, Research, Development & International Affairs, National Health Care Institute, the Netherlands

Members

Patricia Aluko, BPharm, MSc
Global Health Outcomes Lead, Reckitt Benckiser, United Kingdom
Bryan Bennett, PhD 
Head of Patient Centered Outcomes, Senior Director, Jazz Pharma, United Kingdom


Sofie Berghuis, PhD

Market Access Manager, GSK, the Netherlands 
Imre Boncz, MD, MSc, PhD, Habil
Professor & Director, University of Pécs, Hungary

 

Jacoline Bouvy, MSc, PhD
Program Director Medicines Evaluation, NICE, United Kingdom


Thor-Henrik Brodtkorb, PhD
Executive Director, Health Economics, RTI Health Solutions, Sweden
Brian Buysse, PhD
Senior Director Epidemiology, Real World and Late Phase, Syneos Health, Spain

Bill Byrom, PhD
Vice President, Product Intelligence and Positioning, Signant Health, United Kingdom
Issac Corro Ramos, MSc, PhD
Scientific Researcher, Institute for Medical Technology Assessment, the Netherlands

Koen Degeling, PhD
Senior Market Access Manager, GSK, the Netherlands

Lorna Dunning, MSc, MPH
Senior Technical Adviser – Methods, NICE, United Kingdom
Gihan Hamdy El-sisi
Managing Director, HTA Office (Technology Appraisal), Middle East and North Africa, Egypt

Rita Faria
Associate Director, HEOR, Astellas Pharma Europe Ltd, United Kingdom
Ramiro Eugenio Gilardino, MHA, MSc, MD
Global HTA & Access Policy Lead, MSD, Zurich, Switzerland

Michael Herdman, MSc
Head of Health Outcomes, Office of Health Economics, Spain
Iñaki Imaz-Iglesia, MD, PhD, MPH
Director, National School of Public Health, Institute of Health “Carlos III” (AETS-ISCIII), Spain

Seamus Kent, MSc, PhD
Assistant Professor, Erasmus University Rotterdam, the Netherlands

Irina Kinchin, MSc, PhD
Research Assistant Professor, Trinity College Dublin, Ireland

Lotte Klim
Sr. Recruitment & Retention Manager, LEO Pharma, Denmark

Ka Keat Lim, MPharm, MSc, PhD
Lecturer in Health Economics, Queen Mary University of London, London, United Kingdom

Laura McCullagh, BSc (Pharm), PhD
Head of Research, Chief I Pharmacist, National Centre for Pharmacoeconomics, NCPE Ireland & Clinical Senior Lecturer, Pharmacology & Therapeutics, Trinity College Dublin, Ireland

Borislava Mihaylova
Professor of Health Economics, Health Economics and Policy Research Unit, Wolfson Institute of Population Health, Queen Mary University of London, United Kingdom & Senior Health Economist, Health Economics Research Centre, University of Oxford, United Kingdom
 
Oresta Piniazhko, PhD
Director of HTA Department, SEC of Ministry of Health of Ukraine, Ukraine


Thomas Rapp, PhD
Professor, Université Paris Cité (LIRAES), Co-director of the Health Policy Research Program, Sciences Po (LIEPP), Senior Advisor, Cepton-Vintura, France

 

Delphine Saragoussi, MD, MScPH
Executive Director, Epidemiology and Scientific Affairs, Evidera, part of the PPD Clinical Research Business of Thermo Fisher Scientific, France

 

Carlos Martín Saborido
Strategy and Innovation Advisor, Ministry of Health, Spain

Anne Spencer
Professor, University of Exeter, United Kingdom
Praveen Thokala, MASc, PhD
Senior Research Fellow, School of Health and Related Research (ScHARR), The University of Sheffield, United Kingdom

Leonor Varela
Professor, Public Health and Preventive Medicine, University of Santiago de Compostela, Spain

Yves Verboven, MSc, Ir
Founder, EU4HealthSolutions, Belgium 

Steffen Wahler, MD
CEO, St. Bernward GmbH, Germany
Nicky J Welton, PhD
Professor of Statistical and Health Economic Modelling, Population Health Sciences, Bristol Medical School, University of Bristol, United Kingdom

 

Olivia Wu, PhD, MSc
Professor, Director of Health Economics and Health Technology Assessment (HEHTA) Research Group, University of Glasgow, United Kingdom